.png){kind=icon}
通过全面的临床前肿瘤学研究服务，包括体外和体内药理学功效模型、体内成像技术以及局灶放射治疗能力，推进您临床前肿瘤学复方的研究。
推动您的癌症研究取得下一个突破
临床前肿瘤学
In 2019 we welcomed the preclinical pharmacology oncology provider, MI Bioresearch, into the Labcorp family. Now you can access hundreds of cell line assays and tumor models, as well as thousands of potential oncology patients for clinical trials or explore an extensive library of oncology diagnostics.
When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to move life-changing drug candidates through non-GLP, preclinical development and oncology clinical trials quickly and efficiently.
我们已帮助数百家公司发现了他们的下一个改善生活质量的复方。
免疫治疗和过继性细胞疗法支持
We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. 我们正在不断改善和扩展过继性细胞疗法的能力：
PRECLINICAL ONCOLOGY RENOVATION
从一开始就全力投入抗癌工作
与癌症的斗争始于实验室。这就是我们斥资翻修，将我们位于密歇根州安娜堡的临床前肿瘤学设施的规模扩大了一倍的原因所在。在这里，您可以发现更强大的实力和能力，以加快您的临床前肿瘤学项目。
让我们开始对话
联系我们
